Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;73(2):185-7.
doi: 10.1016/j.jhin.2009.05.013. Epub 2009 Aug 26.

Elevated Levels of Intestinal Inflammation in Clostridium Difficile Infection Associated With Fluoroquinolone-Resistant C. Difficile

Free PMC article

Elevated Levels of Intestinal Inflammation in Clostridium Difficile Infection Associated With Fluoroquinolone-Resistant C. Difficile

S W Pawlowski et al. J Hosp Infect. .
Free PMC article

Conflict of interest statement

Conflict of interest statement: R.L.G. is licensed fecal lactoferrin to TechLab Inc. D.M.L., R.J.C., and C.W.G. are TechLab employees. D.N.G. consults for ViroPharma, Genzyme, Optimer, Salix, and Schering–Plough and holds research grants from ViroPharma, Optimer, Massachusetts Biological Laboratories, Cepheid, and GOJO Industries.

Figures

Figure 1
Figure 1
24 (71%) fecal specimens had lactoferrin levels ≤72.5 μg/g. A. Of the 10 specimens with lactoferrin levels >72.5, all were associated with the presence of moxifloxacin resistant isolates; in addition, all susceptible isolates were associated with lower lactoferrin levels (X2, p=0.041). B. There was no correlation between elevated lactoferrin levels and the presence of the 18-bp tcdC deletion (X2, p=0.44)

Similar articles

See all similar articles

Cited by 8 articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback